CHEMOTHERAPY-INTOLERANT

Clinical trials for CHEMOTHERAPY-INTOLERANT explained in plain language.

Never miss a new study

Get alerted when new CHEMOTHERAPY-INTOLERANT trials appear

Sign up with your email to follow new studies for CHEMOTHERAPY-INTOLERANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Custom cancer vaccine trial offers hope for Chemotherapy-Intolerant patients

Disease control Recruiting now

This early-phase study is testing a personalized mRNA vaccine designed to target a patient's specific cancer, combined with an immunotherapy drug (PD-1 inhibitor). It is for people who have had surgery for pancreatic cancer but cannot tolerate standard chemotherapy. The main goal…

Matched conditions: CHEMOTHERAPY-INTOLERANT

Phase: EARLY_PHASE1 • Sponsor: Ruijin Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

CHEMOTHERAPY-INTOLERANT

Get alerted when new CHEMOTHERAPY-INTOLERANT trials appear

Custom cancer vaccine trial offers hope for Chemotherapy-Intolerant patients